FDA OKs Zimmer Biomet Persona Revision knee replacement device

|About: Zimmer Biomet Holdings... (ZBH)|By:, SA News Editor

The FDA issues 510(k) clearance for Zimmer Biomet Holdings' (ZBH -0.6%) Persona Revision Knee System for revision knee replacement procedures. Market launch in the U.S should commence in the coming weeks.

The company says the device features anatomic components designed to match the patient's anatomy for a personalized fit.

Subscribe for full text news in your inbox